LCGC
ROIV icon

Legacy Capital Group California’s Roivant Sciences ROIV Stock Holding History

Legacy Capital Group California’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672K Buy
18,999
+2,446
+15% +$72.3K 0.2% 148
2026
Q1 		$459K Sell
16,553
-4,609
-22% -$118K 0.17% 183
2025
Q4 		$459K Buy
+21,162
New +$418K 0.11% 226

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Legacy Capital Group California's ROIV Position: Q2 2026 in Review

Legacy Capital Group California increased its Roivant Sciences (ROIV) stake by 15% in Q2 2026, buying an estimated $72.3K and bringing the position to 18,999 shares worth $672K. The position accounts for 0.2% of the portfolio, ranked #148.

Legacy Capital Group California first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Legacy Capital Group California held 18,999 shares of Roivant Sciences worth $672K as of Q2 2026.
  • Legacy Capital Group California bought 2,446 Roivant Sciences shares in Q2 2026, an estimated $72.3K.
  • Roivant Sciences made up 0.2% of Legacy Capital Group California's portfolio in Q2 2026, its #148 holding.
  • Legacy Capital Group California first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.